Clinical Trial Update: ADVANCE Study of DTG + TAF + FTC vs DTG + TDF + FTC and EFV + TDF+FTC in First-line Antiretroviral Therapy [Phase 3]

View source ↗

Summary

Phase 3 trial update comparing DTG + TAF + FTC vs DTG + TDF + FTC and EFV + TDF + FTC in first-line antiretroviral therapy for HIV-1 infection; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• DTG + TDF + FTC
• DTG/TAF/FTC (dolutegravir/tenofovir alafenamide/emtricitabine)
• EFV-TDF-FTC

Snippet

Sponsor: Professor Francois Venter | Conditions: HIV-1 Infection | Phase 3 | Status: COMPLETED